Skip to main content

Sio Gene Therapies Inc.

SIOXDelisted Apr 12, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001636050

Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Sio Gene Therapies Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

SIOX is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022

Institutional holders
1
−3 vs. Q1 2023
Shares held
64.2K
−2.73M (−97.7%) vs. Q1 2023
Total value
$26.0K
−$1.11M (−97.7%) vs. Q1 2023
New holders
0
0 more added
Sold out
3
0 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SIOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 1 institution
Q1 2021: 55 institutionsQ2 2021: 53 institutionsQ3 2021: 55 institutionsQ4 2021: 48 institutionsQ1 2022: 40 institutionsQ2 2022: 41 institutionsQ3 2022: 38 institutionsQ4 2022: 37 institutionsQ1 2023: 4 institutionsQ2 2023: 1 institutionQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $26.0K
Q1 2021: $53.2MQ2 2021: $56.1MQ3 2021: $39.9MQ4 2021: $27.6MQ1 2022: $12.1MQ2 2022: $7.44MQ3 2022: $5.91MQ4 2022: $8.09MQ1 2023: $1.13MQ2 2023: $26.0KQ3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SIOX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20231$26.0K
Q1 20234$1.13M
Q4 202237$8.09M
Q3 202238$5.91M
Q2 202241$7.44M
Q1 202240$12.1M
Q4 202148$27.6M
Q3 202155$39.9M
Q2 202153$56.1M
Q1 202155$53.2M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Sio Gene Therapies Inc.; share changes are against Q1 2023.

Institutions holding SIOX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Macquarie Group Ltd64,170$26.0K0.00%00.0%Unchanged
JBF Capital, Inc.0$00.00%−2,639,127−100.0%Sold out
Cladis Investment Advisory, LLC0$00.00%−80,000−100.0%Sold out
Baader Bank INC0$00.00%−14,000−100.0%Sold out